PHILADELPHIA, March 10, 2025 (GLOBE NEWSWIRE) — Berger Montague PC advises investors that a securities class action lawsuit has been filed against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ:TMDX) on behalf of purchasers of TransMedics securities between February 28, 2023 through January 10, 2025, inclusive (the “Class Period”).
Investor Deadline: Investors who purchased or acquired TRANSMEDICS securities during the Class Period may, no later than APRIL 15, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.
TransMedics, headquartered in Andover, Mass., is a medical technology company that offers transplant services, including its Organ Care System (OCS), a portable organ preservation system that replicates physiologic conditions.
According to the lawsuit, throughout the Class Period, the Company and its senior executives misled investors and/or failed to disclose that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics concealed safety issues and a lack of safety oversight within …
